摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(2-isopropoxyphenyl)-2,2-dimethylpropan-1-one

中文名称
——
中文别名
——
英文名称
1-(2-isopropoxyphenyl)-2,2-dimethylpropan-1-one
英文别名
2,2-Dimethyl-1-(2-propan-2-yloxyphenyl)propan-1-one;2,2-dimethyl-1-(2-propan-2-yloxyphenyl)propan-1-one
1-(2-isopropoxyphenyl)-2,2-dimethylpropan-1-one化学式
CAS
——
化学式
C14H20O2
mdl
——
分子量
220.312
InChiKey
FSCNGZIDSMJERD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.8
  • 重原子数:
    16
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    1-(2-isopropoxyphenyl)-2,2-dimethylpropan-1-one 在 ammonia borane 、 C68H65O4PSi2 作用下, 以 二硫化碳 为溶剂, 反应 12.0h, 以74%的产率得到
    参考文献:
    名称:
    氨硼烷催化手性磷酸催化大体积芳基酮的不对称转移加氢
    摘要:
    以手性磷酸(CPA)为催化剂,水为添加剂,成功实现了氨硼烷对大体积芳基酮的不对称转移加氢反应。以高至高收率获得了多种旋光仲醇,ee高达77%。该反应可能是通过布朗斯台德酸促进的双氢在酮和氨硼烷之间的六元一致过渡态转移而进行的。
    DOI:
    10.1016/j.tetlet.2019.151394
  • 作为产物:
    参考文献:
    名称:
    氨硼烷催化手性磷酸催化大体积芳基酮的不对称转移加氢
    摘要:
    以手性磷酸(CPA)为催化剂,水为添加剂,成功实现了氨硼烷对大体积芳基酮的不对称转移加氢反应。以高至高收率获得了多种旋光仲醇,ee高达77%。该反应可能是通过布朗斯台德酸促进的双氢在酮和氨硼烷之间的六元一致过渡态转移而进行的。
    DOI:
    10.1016/j.tetlet.2019.151394
点击查看最新优质反应信息

文献信息

  • OXAZOLE OREXIN RECEPTOR ANTAGONISTS
    申请人:MERCK SHARP & DOHME CORP.
    公开号:US20160176858A1
    公开(公告)日:2016-06-23
    The present invention is directed to oxazole compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the oxazole compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to pharmaceutical compositions comprising these compounds. The present invention is also directed to uses of these pharmaceutical compositions in the prevention or treatment of such diseases in which orexin receptors are involved.
    本发明涉及噁唑化合物,其是促进睡眠的荷尔蒙受体的拮抗剂。本发明还涉及这些噁唑化合物在潜在的神经和精神障碍和疾病的治疗或预防中的应用,其中涉及到促进睡眠的荷尔蒙受体。本发明还涉及包含这些化合物的制药组合物。本发明还涉及这些制药组合物在预防或治疗涉及促进睡眠的荷尔蒙受体的疾病中的应用。
  • THIOETHER-PIPERIDINYL OREXIN RECEPTOR ANTAGONISTS
    申请人:MERCK SHARP & DOHME CORP.
    公开号:US20160318899A1
    公开(公告)日:2016-11-03
    The present invention is directed to thioether-piperidinyl compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the thioether-piperidinyl compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to pharmaceutical compositions comprising these compounds. The present invention is also directed to uses of these pharmaceutical compositions in the prevention or treatment of such diseases in which orexin receptors are involved.
  • US9617246B2
    申请人:——
    公开号:US9617246B2
    公开(公告)日:2017-04-11
  • US9828368B2
    申请人:——
    公开号:US9828368B2
    公开(公告)日:2017-11-28
  • Chiral phosphoric acid catalyzed asymmetric transfer hydrogenation of bulky aryl ketones with ammonia borane
    作者:Qiwen Zhou、Wei Meng、Xiangqing Feng、Haifeng Du、Jing Yang
    DOI:10.1016/j.tetlet.2019.151394
    日期:2020.1
    An asymmetric transfer hydrogenation of bulky aryl ketones with ammonia borane was successfully realized with chiral phosphoric acid (CPA) as catalyst and water as additive. A variety of optically active secondary alcohols were obtained in good to high yields with up to 77% ee. The reaction likely proceeded through a Brønsted acid-promoted double-hydrogen transfer between ketones and ammonia borane
    以手性磷酸(CPA)为催化剂,水为添加剂,成功实现了氨硼烷对大体积芳基酮的不对称转移加氢反应。以高至高收率获得了多种旋光仲醇,ee高达77%。该反应可能是通过布朗斯台德酸促进的双氢在酮和氨硼烷之间的六元一致过渡态转移而进行的。
查看更多